PRODUCT

Chonluten (20 mg Vial)

No short description available.

Quickstart Highlights

Chonluten is a short bioregulatory tripeptide (Glu‑Asp‑Gly) studied for its effects on bronchopulmonary tissue and inflammatory pathways in monocyte/macrophage cell models[1]. As a small peptide with poor oral stability, subcutaneous injection is the indicated parenteral route[2]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration.
Typical daily range: 250–4,000 mcg once daily (gradual titration over 8–16 weeks).
Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.67 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: refrigerate at 4 °C (39.2 °F) short‑term or freeze at −20 °C (−4 °F) long‑term; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Reconstitution

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Support bronchopulmonary tissue function and modulate inflammatory pathways[1].
Schedule:Daily subcutaneous injections for 8–16 weeks with gradual titration.
Dose Range:250–4,000 mcg daily with incremental increases every 1–2 weeks.
Reconstitution:3.0 mL per 20 mg vial (6.67 mg/mL) for accurate unit measurements.
Storage:Lyophilized refrigerated or frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosage Protocols

Start:250 mcg daily; increase by 250–500 mcg every 1–2 weeks as tolerated.
Target:Up to 4,000 mcg daily by Weeks 13–16.
Frequency:Once per day (subcutaneous).
Cycle Length:8–16 weeks; shorter durations (8–12 weeks) acceptable.
Timing:Any consistent time; rotate injection sites.

Storage Instructions

Lyophilized:Proper storage preserves peptide quality[3]. Lyophilized (short‑term): Refrigerate at 4 °C (39.2 °F) in dry, dark conditions. Lyophilized (long‑term): Store at −20 °C (−4 °F) or colder; minimize moisture exposure. Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within days to weeks and avoid freeze–thaw. Allow vials to reach room temperature before opening to reduce condensation uptake.
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within days to weeks and avoid freeze–thaw.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes; dispose in a sharps container[6].
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
For initial low‑volume doses (≤10 units), use 30‑ or 50‑unit insulin syringes for improved accuracy.

How It Works

Chonluten (Glu‑Asp‑Gly) is a short bioregulatory peptide studied within the Khavinson peptide bioregulator framework targeting bronchopulmonary tissues[1]. In vitro research using monocyte/macrophage (THP‑1) cell models indicates Chonluten may modulate proliferative activity and inflammatory pathways at concentrations in the nanomolar range[1]. Short peptides such as Chonluten typically exhibit poor oral bioavailability due to enzymatic degradation and limited mucosal permeability, supporting subcutaneous administration as the preferred route[2][5].

Lifestyle Factors

Maintain a balanced diet rich in antioxidants to support respiratory tissue health.
Engage in regular aerobic activity appropriate to fitness level.
Prioritize sleep and stress management to support immune function and recovery.
Avoid smoking and minimize exposure to respiratory irritants.

Injection Technique

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45° into subcutaneous tissue using a 25–27 gauge, ⅝‑inch needle[4].
Do not aspirate for subcutaneous injections; inject slowly and steadily[4].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[8].

Benefits and Side Effects

Benefits

May support bronchopulmonary tissue function and respiratory cell regulation based on bioregulator peptide research[1].
Cell‑culture studies suggest modulation of inflammatory and proliferative pathways in monocyte/macrophage models[1].
Short peptides in this class generally show favorable tolerability profiles in preclinical settings[5].

Side Effects

Occasional mild injection‑site reactions (redness/itch) may occur with subcutaneous administration.

Chonluten (20 mg Vial)

Resources

Categories

Company